MagicMed Industries CEO Dr Joseph Tucker tells Proactive the group will present at KCSA Strategic Communications' psychedelic-focused investor event on January 26th and 27th.
Dr Tucker says the privately-held group's business model consists of developing new psilocybin-based molecules, and then licensing these molecules to partner companies.